Sagent Pharmaceuticals launches caffeine citrate injection and oral solution

Schaumburg, Illinois Saturday, October 06, 2012, 16:00 Hrs[IST] Sagent Pharmaceuticals, Inc. has launched caffeine citrate injection, USP and caffeine citrate oral solution, USP, central nervous system stimulants, in two latex-free vial presentations. According to IMS, for the 12 months ending July 2012, the US market for caffeine citrate injection, USP and caffeine citrate oral solution, USP approximated $28.5 million.As with all products in Sagent's portfolio, Caffeine features the company's PreventIV MeasuresSM packaging and labeling, designed to help reduce medication errors.Caffeine Citrate Injection, USP and Caffeine Citrate Oral Solution, USP are indicated for the short-term treatment of apnea of prematurity in infants between 28 and less than 33 weeks gestational age.Sagent Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables.